Why Young Indians Are Developing Diabetes and Fatty Liver Earlier Than Ever

India is witnessing a troubling health trend: younger individuals are increasingly diagnosed with diabetes, fatty liver disease, and heart conditions despite having lower average body mass index (BMI) compared to Western populations.

This paradox highlights unique metabolic vulnerabilities in the Indian population.

Experts like Dr.

Ajay Phadke emphasize that traditional markers such as BMI may not fully capture the risk profile for these diseases in Indians.

Factors such as genetic predisposition, dietary patterns, and sedentary lifestyles contribute to earlier onset of metabolic disorders.

Early testing and diagnosis are critical to managing this growing burden.

The World Health Organization (WHO) has recently issued guidance endorsing the use of GLP-1 receptor agonists, a class of drugs that improve blood sugar control and aid weight management, as part of a comprehensive approach to diabetes care.

Additionally, advances in artificial intelligence (AI) diagnostics are enhancing the ability to detect fatty liver and cardiovascular risks at earlier stages, enabling timely interventions.

Public health strategies in India must adapt to these insights by promoting awareness, screening younger populations, and integrating novel therapies and technologies.

Addressing this health crisis requires a multifaceted approach involving lifestyle modification, medical treatment, and technological innovation to reduce the long-term impact of these diseases on India's youth and healthcare system.